Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Image Analysis for Cancer

Back to the Program-at-a-Glance

Image Analysis for Cancer
Digital Poster
Analysis Methods
Tuesday, 12 May 2026
Digital Posters Row D
16:55 - 17:50
Session Number: 463-06
No CME/CE Credit
This session will cover the development and validation of image analysis approaches applied to applications in cancer.

  Figure 463-06-001.  The Value of Gadoxetate Disodium-Enhanced MRI Habitat Imaging in Preoperative Prediction of Proliferative HCC
Zhimin Yu, Chengyu Ding, Xueqin Zhang
Nantong University, Nantong, China
Impact: The nomogram model based on gadoxetate disodium-enhanced MRI habitat imaging demonstrates potential for predicting proliferative hepatocellular carcinoma and exhibits favorable capability for prognostic risk stratification.
  Figure 463-06-002.  DCE-MRI Morphometric Assessment Predicts Chemotherapy Response in Colorectal Liver Metastasis
HUAN ZHANG, Tong Tong
Fudan University Shanghai Cancer Center, Shanghai, China
Impact: This study reveals the potential role of morphometric features in predicting chemotherapy response in CRLM, providing a practical and effective tool for clinical decision-making.
  Figure 463-06-003.  Multiparametric 18F-FDG PET/MRI Reveals Intratumoral Heterogeneity for Differentiating Benign and Malignant Solitary Pulmonar
Nan Meng, Qianqian Chen, Xinyu Wang, Yue Liu, Xuan Yu, Qiuyu Ji, Zhe Wang, Yang Yang, Meiyun Wang
Henan Provincial People's Hospital, Zhengzhou, China
Impact: Multiparametric 18F-FDG PET/MRI habitat imaging enables non-invasive differentiation of benign and malignant solitary pulmonary lesions by quantifying intratumoral spatial heterogeneity. This approach reveals distinct subregional patterns and provides novel imaging biomarkers with potential clinical utility for precision diagnosis and management.
  Figure 463-06-004.  Habitat analysis and peritumoral radiomics for predicting castration resistance in prostate cancer patients
hongyan Gao, Wenjia Wang, hui Wu
Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China
Impact: Habitat analysis can predict the likelihood of CRPC development in PCa patients by resolving intratumoral heterogeneity. The peritumoral radiomics model holds independent predictive value for CRPC, and integrating peritumoral radiomic features can further enhance model performance.
  Figure 463-06-005.  The value of foundation model-driven multiomics for predicting platinum resistance in HGSOC patients
Qiu Bi, Li Wu, Yunzhu Wu, Meining Chen
The First People’s Hospital of Yunnan Province. The Affiliated Hospital of Kunming University of Science and Technology, kunming, China
Impact: 
  • This study carries the potential to equip clinicians with treatment strategies aimed at enhancing the efficacy of individualized therapy.
  Figure 463-06-006.  Multiparametric MRI in the Discrimination of Progression from Atypical Endometrial Hyperplasia to Stage IA Endometrial Cancer
Qingwen Xiao, Lingtao Zhang, wei cui, Dong Zhang, Liangping Luo, Changzheng Shi
The First Affiliated Hospital of Jinan University, Guangzhou, China
Impact: This study confirms the critical role of multiparametric MRI in differentiating AH from Stage IA EC, paving the way for a reliable, non-invasive approach to clinical diagnosis.
  Figure 463-06-007.  Noninvasive Assessment of Bladder Cancer Staging and Grading Using Continuous-Time Random Walk-Based Habitat Analysis
Ding Li, Xiaochun Wang
First Hospital of Shanxi Medical University, Taiyuan, China
Impact: 

Our results show that CTRW-derived parameters, particularly in Habitat 2, effectively distinguish staging and grading subgroups. A combined model incorporating imaging and clinical factors achieved strong predictive performance, highlighting its potential as a noninvasive diagnostic tool.
  Figure 463-06-008.  Automated Lesion Detection of Deep Learning-based Phase Corrected Single-Shot rFOV Diffusion Images of the Prostate
Eugene Milshteyn, Xinzeng Wang, Patricia Lan, Arnaud Guidon, Adele Courot, Nicolas Gogin, Nabih Nakrour, Ranjodh Dhami, William Bradley, Mukesh Harisinghani, Rory Cochran
GE HealthCare, San Ramon, United States of America
Impact: DL Phase Correction improves the signal-to-noise ratio and IQ of prostate DWI over current commercial DL reconstructions, while showing compatibility with an investigational automated prostate lesion detection tool.
  Figure 463-06-009.  Radiomic feature analyses reveal imaging biomarkers correlated with PI-RADS lesion classification in prostate cancer MRI.
Savannah Duenweg, Michael Barrett, Samuel Bobholz, Allison Lowman, Biprojit Nath, Aleksandra Winiarz, Hope Reecher, Fitzgerald Kyereme, Stephanie Vincent-Sheldon, Kathleen Bhatt, Katherine Troy, Michael Kim, Eric Fair, William Hall, Peter LaViolette
Medical College of Wisconsin, Milwaukee, United States of America
Impact: Radiomic features calculated on clinical multiparametric MRI strongly correlate with PI-RADS classifications. These features may provide quantitative biomarkers to aid diagnostic confidence for indeterminate PI-RADS lesions and reduce inter-rater variability.
  Figure 463-06-010.  A Biparametric MRI-based Deep Transfer Learning and Radiomics Model for Diagnosing Clinically Significant Prostate Cancer
Xuelian Zhao, NING ZHANG, fei jia, Guang Liu, Yanli Jiang, Jing Zhang, Kai AI
The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
Impact: This study provides a critical foundation for optimizing prostate biopsy decisions. It can potentially reduce unnecessary procedures and improve patient management, demonstrating significant promise for clinical translation.
  Figure 463-06-011.  MRI in Diagnosing Lumbar Spine Chordoma: Insights from a Low-Resource Environment
Chikumbutso Khomba, Osward Bwanga, Lloyd Likato
Affidea Diagnostic, Dublin, Ireland
Impact: This case demonstrates how MRI can act as a surrogate diagnostic adjunct in settings with limited access to histopathology. By guiding early surgical planning and multidisciplinary care for spinal chordoma, MRI enhances clinical decision-making and promotes equitable cancer management.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine